Shopping Cart -

Your cart is currently empty.
Continue Shopping
This website use cookies and similar technologies to improve the site and to provide customised content and advertising. By using this site, you agree to this use. To learn more, including how to change your cookie settings, please view our Cookie Policy
Pocketmags Digital Magazines
Pocketmags Digital Magazines
   You are currently viewing the Australia version of the site.
Would you like to switch to your local site?
Digital Subscriptions > Newsweek International > 28 July - 4th August 2017 > You Can Get There From Here

You Can Get There From Here

Sometimes, a cancer patient’s best chance is getting into a clinical trial. But finding the right one can be as hard as finding an IV in a haystack



When Tom Marsilje’s cancer came back stronger in August 2013, he knew he would eventually have to turn to a clinical trial.

These trials, which test the safety and eficacy of experimental treatments compared with the standard of care, are not for every patient, because some types of cancer have good treatment options with strong outcomes. Marsilje’s initial search returned 1,200 results. “With my patient hat on, I had no idea where you’d start. I assure you, there are not 1,200 clinical trials [worth considering],” Marsilje says. “One of the first things I realized was that I was really lucky in my background. I don’t know how anyone without a scientific background would be able to do this. It’s so complicated.”

Purchase options below
Find the complete article and many more in this issue of Newsweek International - 28 July - 4th August 2017
If you own the issue, Login to read the full article now.
Single Issue - 28 July - 4th August 2017
Or 799 points
Annual Digital Subscription
Only $ 1.04 per issue
Or 5299 points
Monthly Digital Subscription
Only $ 1.41 per issue
Or 599 points

View Issues

About Newsweek International

CANCER REBELS For this year's Special Health Issue, we've focused on the Cancer Rebels, the women, men and children who ignore the rules and scorn the conventions that surround cancer, and who refuse to succumb to the disease. These are the people who find vitality in taking on cancer from unexpected directions.